Table 3. Clinical outcomes by PL use over time.
Low PL Use | High PL Use | ||||
---|---|---|---|---|---|
Viral Suppression | N | Percent Suppressed | N | Percent Suppressed | p-value |
6 months | 33 | 78.8 | 53 | 94.6 | 0.03 |
12 months | 30 | 76.7 | 23 | 87.0 | 0.48 |
18 months | 15 | 86.7 | 22 | 90.9 | 0.99 |
24 months | 13 | 69.2 | 18 | 94.4 | 0.13 |
Engagement in Care | N | Percent Engaged | N | Percent Engaged | p-value |
6 months | 39 | 87.2 | 59 | 93.2 | 0.48 |
12 months | 38 | 73.7 | 27 | 88.9 | 0.21 |
18 months | 22 | 77.3 | 23 | 95.7 | 0.10 |
24 months | 20 | 75.0 | 18 | 88.9 | 0.41 |
Table 3 shows the observed outcomes by level of PL use. PL members are included in a given time point for which they were actively enrolled in PL, defined as receiving daily queries for at least 5.5 months of the 6-month interval. Members who responded to ≥48% of daily queries in the prior 6-months are classified as high PL users; those with <48% response rates are low users. Viral suppression is defined as having a viral load <200 copies/mL. Engagement in care is defined as having attended 2 or more HIV appointments separated by at least 90 days within the past year.